MedMen terminates $682 million deal to buy Chicago-based marijuana company PharmaCann as cannabis stocks lose their sizzle

But MedMen is still expanding its presence in Illinois. In exchange for forgiveness of certain debt, PharmaCann will transfer ownership of one marijuana grow facility, one retail facility, and a license to open another retail facility in Illinois to MedMen, just months before recreational sales start in the state.